通过口服避孕药使用预防卵巢癌的表观遗传假设
Anna S Avramenko1, James M Flanagan2
1Division of Cancer, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, 4th Floor IRDB, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.
Clinical epigenetics
|October 18, 2023
概括
联合口服避孕药 (COCPs) 可能通过改变表观基因组来预防卵巢癌. 本综述探讨了COCP背后的分子机制.
科学领域:
- 妇科瘤学 妇科瘤学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 化学预防 化学预防
背景情况:
- 卵巢癌是全球妇科癌症死亡的主要原因之一.
- 晚期诊断和缺乏早期生物标志物有助于低生存率.
- 可修改的生活方式因素,如联合口服避孕药 (COCPs) 显示出预防潜力.
研究的目的:
- 审查支持COCPs化学预防作用的新假设的证据.
- 调查COCPs对卵巢癌起源表观基因组的影响.
- 探索卵巢癌预防的分子机制.
主要方法:
- 关于COCPs和卵巢癌的现有数据的文献综述.
- 分析与COCP使用相关的表观遗传变化.
- 专注于输卵管上皮作为卵巢癌的起源.
主要成果:
- 在卵巢癌中可以检测到表观遗传改变,这可能是预防的关键.
- 越来越多的数据表明表观遗传学在长期预防卵巢癌中的作用.
- 本文重点研究的是COCPs对表观基因组产生影响的假设.
结论:
- 联合口服避孕药 (COCPs) 可能起到化学预防剂的作用.
- 假设COCPs的化学预防通过表观遗传修饰发生.
- 输卵管表皮被认为是受COCPs影响的细胞起源.
相关概念视频
Oogenesis
63.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.8K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Hormonal Control of the Ovarian Cycle
538
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
538
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Hormonal Regulation of the Menstrual Cycle
408
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
408
Ovarian Cycle
1.3K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.3K


